Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Experimental drug aims to save heart muscle during heart attack

NCT ID NCT07306182

Summary

This study is testing whether a new, single-dose injection called SGC001 can help reduce permanent heart damage in people who are having a major heart attack affecting the front of the heart. The drug is given during emergency treatment to open a blocked artery. Researchers will compare SGC001 to a placebo (dummy injection) in 210 Chinese patients to see if it better protects the heart muscle and prevents future heart problems.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTERIOR MYOCARDIAL INFARCTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.